Immunome (IMNM)

Immunome (IMNM) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• IMNM last traded at $19.39, 6.48% on the day.
• Immunome: P/E -7.6, revenue $12.59M over the last four quarters.
• Over the past year IMNM returned 21.34%; year to date -9.73%.

Updated 2026-11-02 17:49 UTC